There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Intuitive Surgical (ISRG – Research Report) and IGM Biosciences (IGMS – Research Report) with bullish sentiments.
Intuitive Surgical (ISRG)
In a report released today, Larry Biegelsen from Wells Fargo assigned a Buy rating to Intuitive Surgical, with a price target of $549.00. The company’s shares closed last Thursday at $473.73, close to its 52-week high of $496.48.
According to TipRanks.com, Biegelsen is a 5-star analyst with an average return of
Currently, the analyst consensus on Intuitive Surgical is a Moderate Buy with an average price target of $521.18, which is an 8.3% upside from current levels. In a report issued on October 7, BTIG also maintained a Buy rating on the stock with a $494.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
IGM Biosciences (IGMS)
In a report released today, Brian Abrahams from RBC Capital maintained a Buy rating on IGM Biosciences, with a price target of $20.00. The company’s shares closed last Thursday at $16.03.
According to TipRanks.com, Abrahams is a 4-star analyst with an average return of
IGM Biosciences has an analyst consensus of Moderate Buy, with a price target consensus of $19.89.
Read More on ISRG:
- Intuitive Surgical price target raised to $535 from $518 at BTIG
- Intuitive Surgical price target raised to $565 from $503 at Baird
- Intuitive Surgical price target raised to $538 from $495 at Piper Sandler
- Closing Bell Movers: Netflix gains 5% as Q3 earnings, Q4 guidance top estimates
- ISRG Earnings: Intuitive Surgical’s Financial Results Beat Estimates
